Feb 2026 $30 M Private placement after listing $10 to $50 million 14
PAVmed Inc.: Private sale, Feb 2026 × Investors in this round 14 investors had bought by the notice of Feb 17, 2026: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $30 M of $60 M offered; $30 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dennis M. McGrath · Executive Officer Lishan Aklog · Executive Officer, Director Michael A. Gordon · Executive Officer Shaun M. O'Neil · Executive Officer Debra J. White · Director Michael J. Glennon · Director Ronald M. Sparks · Director Sundeep J. Agrawal · Director Timothy E. Baxter · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The company sold 30,000 shares of Series D Convertible Preferred Stock at $1,000 per share, with the investors receiving warrants to purchase an additional 30,000 shares of Series D Convertible Preferred Stock at $1,000 per share.”Signed by Dennis M. McGrath, President and Chief Financial Officer. Source: SEC Form D, newest notice filed Feb 17, 2026. Read the notice at the SEC .
equity, options SEC Jan 2025 $3 M Private placement after listing $2 to $10 million 1
PAVmed Inc.: Private sale, Jan 2025 × Investors in this round 1 investor had bought by the notice of Feb 7, 2025: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue $1 million to $5 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dennis M. McGrath · Executive Officer Lishan Aklog · Executive Officer, Director Michael A. Gordon · Executive Officer Shaun M. O'Neil · Executive Officer Debra J. White · Director Michael J. Glennon · Director Ronald M. Sparks · Director Sundeep J. Agrawal · Director Timothy E. Baxter · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Dennis M. McGrath, President and Chief Financial Officer. Source: SEC Form D, newest notice filed Feb 7, 2025. Read the notice at the SEC .
equity SEC Aug 2020 $8 M Private placement after listing $2 to $10 million 1
PAVmed Inc.: Private sale, Aug 2020 × Investors in this round 1 investor had bought by the notice of Aug 11, 2020: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $8 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dennis M. McGrath · Executive Officer Lishan Aklog · Executive Officer, Director Richard M. Yazbeck · Executive Officer Shaun M. O'Neil · Executive Officer David S. Battleman, M.D. · Director David Scott Weild, IV · Director James L Cox · Director Michael Glennon · Director Ronald M. Sparks · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Dennis McGrath, President & CFO. Source: SEC Form D, newest notice filed Aug 11, 2020. Read the notice at the SEC .
debt, options SEC Apr 2020 $4 M Private placement after listing $2 to $10 million 1
PAVmed Inc.: Private sale, Apr 2020 × Investors in this round 1 investor had bought by the notice of May 1, 2020: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees $120,250
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dennis M. McGrath · Executive Officer Lishan Aklog · Executive Officer, Director Richard M. Yazbeck · Executive Officer Shaun M. O'Neil · Executive Officer David S. Battleman, M.D. · Director David Scott Weild, IV · Director James L Cox · Director Michael Glennon · Director Ronald M. Sparks · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Maxim Group LLC (CRD 120708) · New York, New York Sold in NY Signed by Dennis McGrath, President & CFO. Source: SEC Form D, newest notice filed May 1, 2020. Read the notice at the SEC .
debt, options SEC Nov 2019 $14 M Private placement after listing $10 to $50 million 2
PAVmed Inc.: Private sale, Nov 2019 × Investors in this round 2 investors had bought by the notice of Nov 7, 2019: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $14 M of $14 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees $819,000
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dennis M. McGrath · Executive Officer Lishan Aklog · Executive Officer, Director Richard M. Yazbeck · Executive Officer Shaun M. O'Neil · Executive Officer David S. Battleman, M.D. · Director David Scott Weild, IV · Director James L. Cox · Director Michael Glennon · Director Ronald M. Sparks · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Maxim Group LLC (CRD 120708) · New York, New York Sold in NY Remarks in the notice On fees: “For further explanation, please see the Current Reporton Form 8-K filed by the Issuer on November 4, 2019.”On the amounts: “For further explanation, please see the Current Report on Form 8-K filed by the Issuer on November 4, 2019.”Signed by Lishan Aklog, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 7, 2019. Read the notice at the SEC .
debt, options SEC Dec 2018 $8 M Private placement after listing $2 to $10 million 1
PAVmed Inc.: Private sale, Dec 2018 × Investors in this round 1 investor had bought by the notice of Jan 9, 2019: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $8 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions none
Finders' fees $455,000
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Brian J. DeGuzman, M.D. · Executive Officer Dennis M. McGrath · Executive Officer Lishan Aklog, M.D. · Executive Officer, Director David S. Battleman, M.D. · Director David Scott Weild, IV · Director James L. Cox, M.D. · Director Michael Glennon · Director Ronald M. Sparks · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Maxim Group LLC (CRD 120708) · New York, New York Sold in NY Signed by Lishan Aklog, M.D., Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 9, 2019. Read the notice at the SEC .
debt, options SEC Jan 2017 $2 M Private placement after listing Under $2 million 13
PAVmed Inc.: Private sale, Jan 2017 × Investors in this round 13 investors had bought by the notice of Feb 7, 2017: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $3 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $105,556
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Lishan Aklog · Executive Officer, Director Richard Fitzgerald · Executive Officer David M. Weild, IV · Director Ira Scott Grenspan · Director James L. Cox · Director Joshua R. Lamstein · Director Michael Glennon · Director Ronald M. Sparks · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Xzerta Trading LLC d/b/a HCFP/Capital Markets (CRD 149111) · New York, New York Sold in CA, CT, NJ, NY Signed by Lishan Aklog, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 7, 2017. Read the notice at the SEC .
equity, debt SEC